# Anti-inflammatory Therapy for Recurrent In-stent Restenosis

> **NCT06090890** · PHASE4 · RECRUITING · sponsor: **Fu Wai Hospital, Beijing, China** · enrollment: 252 (estimated)

## Conditions studied

- In-stent Restenosis

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Prednisone
- **DRUG:** Aspirin
- **DRUG:** P2Y12 Receptor Antagonist
- **DRUG:** Lipid-lowering drug

## Key facts

- **NCT ID:** NCT06090890
- **Lead sponsor:** Fu Wai Hospital, Beijing, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-30
- **Primary completion:** 2026-10-29
- **Final completion:** 2027-10-29
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090890, "Anti-inflammatory Therapy for Recurrent In-stent Restenosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06090890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*